Veru Moves Forward with Late-Stage COVID Study Despite FDA Roadblock

Veru Moves Forward with Late-Stage COVID Study Despite FDA Roadblock

Submitted by admin on March 15, 2023 - 10:13am
Source: 
BioSpace
News Tags: 
Veru
COVID-19
sabizabulin
clinical trials
Headline: 
Veru Moves Forward with Late-Stage COVID Study Despite FDA Roadblock
snippet: 

Weeks after the FDA rejected Veru’s Emergency Use Authorization (EUA) bid for sabizabulin in COVID-19, the company announced plans to continue with late-stage development of the drug.

Do Not Allow Advertisers to Use My Personal information